{"disease":{"id":"contraception","name":"Contraception","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":27,"pipeline_drug_count":0,"trial_count":6},"drugs":{"marketed":[{"drug_id":"etonogestrel","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nexplanon","generic_name":"ETONOGESTREL","company_name":"","drug_phase":"marketed","molecular_target":"Sex hormone-binding globulin","drug_class":"Estrogen [EPC]","quality_score":50,"revenue":"1200","mechanism":""},{"drug_id":"estradiol-vaginal-ring","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Estradiol vaginal ring","company_name":"Oregon Health and Science University","drug_phase":"marketed","molecular_target":"","drug_class":"Estrogen [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"estradiol-valerate","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Delestrogen","generic_name":"ESTRADIOL VALERATE","company_name":"Ph Health","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":65,"revenue":null,"mechanism":"Delestrogen works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"ferrous-fumarate","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Fumarate","generic_name":"FERROUS FUMARATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"norethisterone","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"norethynodrel","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noretynodrel","generic_name":"NORETHYNODREL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"norethynodrel","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"estradiol","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estrace","generic_name":"ESTRADIOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":"Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"norethindrone-acetate","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aygestin","generic_name":"NORETHINDRONE ACETATE","company_name":"Duramed Res","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"medroxyprogesterone","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depo-Provera","generic_name":"medroxyprogesterone","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":null,"revenue":null,"mechanism":"Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy."},{"drug_id":"quingestanol-acetate","indication_name":"Postcoital contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"QUINGESTANOL ACETATE","company_name":"","drug_phase":"phase_2","molecular_target":"Progesterone receptor","drug_class":"quingestanol acetate","quality_score":null,"revenue":null,"mechanism":"Quingestanol acetate works by binding to the progesterone receptor, mimicking the effects of progesterone to prevent ovulation and fertilization."},{"drug_id":"etynodiol","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ethinodiol","generic_name":"etynodiol","company_name":"","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] A","drug_class":"Progestin","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"levonorgestrel","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jadelle","generic_name":"LEVONORGESTREL","company_name":"Fdn Consumer","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":10,"revenue":null,"mechanism":"Jadelle works by binding to the progesterone receptor, which helps to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg."},{"drug_id":"levonorgestrel","indication_name":"Postcoital contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jadelle","generic_name":"LEVONORGESTREL","company_name":"Fdn Consumer","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":10,"revenue":null,"mechanism":"Jadelle works by binding to the progesterone receptor, which helps to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg."},{"drug_id":"endometrin","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endometrin","generic_name":"progesterone","company_name":"Ferring","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"Progesterone [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"estrone","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"ethinylestradiol","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho-Novum 10/11-21","generic_name":"Ethinylestradiol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"estring","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estring","generic_name":"Estradiol","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Ovulation","drug_class":"Combined Oral Contraceptive (COC)","quality_score":71,"revenue":null,"mechanism":"Prevents pregnancy primarily by suppressing ovulation."},{"drug_id":"desogestrel","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho-Cept","generic_name":"DESOGESTREL","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Sex hormone-binding globulin","drug_class":"Progestin","quality_score":52,"revenue":null,"mechanism":""},{"drug_id":"norethindrone","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NORETHINDRONE","company_name":"","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tranexamic-acid","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cyklokapron","generic_name":"TRANEXAMIC ACID","company_name":"Exela Pharma","drug_phase":"marketed","molecular_target":"Plasminogen","drug_class":"Antifibrinolytic Agent [EPC]","quality_score":10,"revenue":null,"mechanism":"Tranexamic acid works by binding to plasminogen and preventing its conversion to plasmin, thereby inhibiting fibrinolysis."},{"drug_id":"estradiol-cypionate","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depoestradiol","generic_name":"ESTRADIOL CYPIONATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor beta","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dienogest","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Natazia","generic_name":"DIENOGEST","company_name":"Mochida Pharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":65,"revenue":null,"mechanism":"Natazia works by binding to the progesterone receptor in the body, mimicking the effects of the natural hormone progesterone."},{"drug_id":"drospirenone","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Slynd","generic_name":"DROSPIRENONE","company_name":"Exeltis Usa Inc","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Progestin","quality_score":75,"revenue":null,"mechanism":"Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation."},{"drug_id":"nonoxinol","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Today","generic_name":"nonoxinol","company_name":"Personal Prods","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":""},{"drug_id":"norelgestromin","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho Evra","generic_name":"NORELGESTROMIN","company_name":"","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":10,"revenue":null,"mechanism":"Ortho Evra works by binding to the progesterone receptor in the body, mimicking the effects of the natural hormone progesterone."},{"drug_id":"mestranol","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norinyl 1+50 28-Day","generic_name":"MESTRANOL","company_name":"","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"metafolin","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metafolin","company_name":"University of California, San Diego","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"progesteron","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Progesteron","company_name":"Minia University","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"amchafibrin","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amchafibrin","company_name":"Fundación Pública Andaluza Progreso y Salud","drug_phase":"phase_3","molecular_target":"Plasminogen","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ferrous-bisglycinate","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Glycinate","generic_name":"FERROUS BISGLYCINATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":41,"revenue":null,"mechanism":"Iron Glycinate works by providing the body with a readily available form of iron that can be easily absorbed and utilized to produce hemoglobin."},{"drug_id":"transamin","indication_name":"Contraception","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"transamin","company_name":"Erzincan Military Hospital","drug_phase":"phase_3","molecular_target":"Plasminogen","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":31,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06125470","title":"SihatMand Khandaan Healthy Families for Pakistan","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":236000,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT06028555","title":"International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study","phase":"","overall_status":"RECRUITING","enrollment_count":101000,"lead_sponsor_name":"Center for Epidemiology and Health Research, Germany","has_results":false},{"nct_id":"NCT03438682","title":"Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization","phase":"","overall_status":"COMPLETED","enrollment_count":89203,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT01266408","title":"INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)","phase":"","overall_status":"COMPLETED","enrollment_count":82921,"lead_sponsor_name":"Center for Epidemiology and Health Research, Germany","has_results":false},{"nct_id":"NCT04666792","title":"PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":25457,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT02527278","title":"Retrospective Claims Analysis of Hysterectomy After Sterilization","phase":"","overall_status":"COMPLETED","enrollment_count":19317,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07403318","title":"Mobile Health Supported Self-care Among Tertiary Education Students in Zimbabwe","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT02349815","title":"JAYDESS Drug Utilization Study in Sweden","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06733831","title":"Family Planning Behaviors, Preferences, Needs and Barriers Within Priority Geographies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9230,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT03088722","title":"A Study Comparing Implant Provision by Community Health Extension Workers With Nurses and Midwives in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":7903,"lead_sponsor_name":"Marie Stopes International","has_results":false},{"nct_id":"NCT02550067","title":"The Evidence for Contraceptive Options and HIV Outcomes Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":7830,"lead_sponsor_name":"FHI 360","has_results":false},{"nct_id":"NCT02759939","title":"Right For Me: Birth Control Decisions Made Easier","phase":"NA","overall_status":"COMPLETED","enrollment_count":5038,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":true},{"nct_id":"NCT05777473","title":"Tipping Point: Using Social Network Theory to Accelerate Scale and Impact","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3825,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT06766396","title":"Predictors of PPIUCD Discontinuation at Two Years: A Clinical Study in Pakistan","phase":"NA","overall_status":"COMPLETED","enrollment_count":3400,"lead_sponsor_name":"Services Institute of Medical Sciences, Pakistan","has_results":false},{"nct_id":"NCT05285670","title":"Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3310,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT01656434","title":"Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":3173,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT05264506","title":"Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":3055,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT04861870","title":"Bandebereho 6 Year Follow up RCT in Rwanda","phase":"NA","overall_status":"COMPLETED","enrollment_count":2818,"lead_sponsor_name":"Promundo, United States","has_results":false},{"nct_id":"NCT02510443","title":"Observational Study on Contraception With Essure in France","phase":"","overall_status":"COMPLETED","enrollment_count":2644,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04092530","title":"Linking Inter-professional Newborn and Contraception Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":2518,"lead_sponsor_name":"Rush University Medical Center","has_results":true},{"nct_id":"NCT03733678","title":"A Randomized-Controlled Trial to Increase the Uptake of LARCs in Cameroon","phase":"NA","overall_status":"COMPLETED","enrollment_count":2500,"lead_sponsor_name":"World Bank","has_results":false},{"nct_id":"NCT03514914","title":"Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":2402,"lead_sponsor_name":"University of California, San Diego","has_results":true},{"nct_id":"NCT02157168","title":"Connecting Healthy Women: Examining the Effect of an Intervention From the Effect of Being Reachable","phase":"NA","overall_status":"COMPLETED","enrollment_count":2267,"lead_sponsor_name":"University of Arizona","has_results":true},{"nct_id":"NCT05889689","title":"Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2250,"lead_sponsor_name":"Trinity Church Inc.","has_results":false},{"nct_id":"NCT00511199","title":"Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2152,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT02817841","title":"E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2148,"lead_sponsor_name":"Estetra","has_results":true},{"nct_id":"NCT04306029","title":"Improving Adherence to Postpartum Family Planning Guidance in Ghana","phase":"NA","overall_status":"COMPLETED","enrollment_count":2142,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03519685","title":"UCSF College Health Study on Contraceptive Training and Education at Community Colleges","phase":"NA","overall_status":"COMPLETED","enrollment_count":2086,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02616146","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2016,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT06579781","title":"Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Child Trends","has_results":false},{"nct_id":"NCT02524288","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1941,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT02710708","title":"YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1921,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05725278","title":"Impact Evaluation of Triggerise's Tiko Platform","phase":"NA","overall_status":"COMPLETED","enrollment_count":1708,"lead_sponsor_name":"Network for Engineering and Economics Research and Management","has_results":false},{"nct_id":"NCT02269241","title":"Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1552,"lead_sponsor_name":"Laboratories Leon Farma, S.A.","has_results":true},{"nct_id":"NCT05461573","title":"Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1542,"lead_sponsor_name":"Insud Pharma","has_results":false},{"nct_id":"NCT04457076","title":"Evaluation of the Efficacy, Safety, and Tolerability of LevoCept","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1525,"lead_sponsor_name":"Sebela Women's Health Inc.","has_results":false},{"nct_id":"NCT00910637","title":"Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1502,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02159261","title":"Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04767139","title":"EPI, a Missed Opportunity for Postpartum Family Planning Utilization","phase":"","overall_status":"COMPLETED","enrollment_count":1474,"lead_sponsor_name":"Hawassa University","has_results":false},{"nct_id":"NCT02403401","title":"Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1471,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05444582","title":"Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1404,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT05927194","title":"Using the Connect: Game Based Intervention","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1400,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03243305","title":"AMP002 Phase III Contraceptive Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1384,"lead_sponsor_name":"Evofem Inc.","has_results":true},{"nct_id":"NCT05240066","title":"Birth Control to Improve Birth Spacing","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1341,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05139121","title":"Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1319,"lead_sponsor_name":"Mylan Technologies Inc.","has_results":false},{"nct_id":"NCT03214848","title":"Evaluation of an Intervention to Increase Post-abortion LARC Uptake.","phase":"NA","overall_status":"COMPLETED","enrollment_count":1314,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT03208985","title":"A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1270,"lead_sponsor_name":"HRA Pharma","has_results":true},{"nct_id":"NCT03765255","title":"Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth","phase":"NA","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03065842","title":"A Pre and Post Test Intervention Design to Prevent Abortion and Contraceptive-use Stigma Among School Youths in Kenya","phase":"NA","overall_status":"COMPLETED","enrollment_count":1207,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03182140","title":"KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method","phase":"","overall_status":"COMPLETED","enrollment_count":1134,"lead_sponsor_name":"Bayer","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}